External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC

Conditions:   RET-fusion Non Small Cell Lung Cancer;   Lung Neoplasm;   Carcinoma, Non-Small-Cell Lung;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Neoplasms by Site;   Neoplasms;   Lung Diseases;   Respiratory Tract Diseases;   Carcinoma, Bronchogenic;   Bronchial Disea ses;   Head and Neck Neoplasms;   Carcinoma;   Neoplasms by Histologic Type;   Neoplasms, Germ Cell and Embryonal;   Neoplasms, Nerve Tissue;   Metastatic Non Small Cell Lung Cancer Intervention:   Sponsors:   Blueprint Medicines Corporation;   Analysis Group, Inc. Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials